All Stories

  1. Proteomic and extracellular particle changes in preterm neonates with suspected late-onset sepsis
  2. Extracellular vesicle phenotypes in Anti-Neutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis: a pilot study
  3. Differential platelet-derived extracellular vesicle signatures in preeclampsia with and without intrauterine growth restriction
  4. PB2222 A Cardiovascular-associated Proteomic Signature Without Alteration in Circulating Extracellular Vesicles in Neonatal Late-Onset Sepsis
  5. Identifying Platelet Lipidomic Networks and Evaluating Machine-Learning Models to Identify Distinctive Features Between Chronic and Acute Coronary Syndrome
  6. Chapter 7: Transforming Preeclampsia Care Through Cross-disciplinary Innovation: From Platelet Biomarkers to Real-time Clinical Decision Support
  7. Comparing extracellular vesicle enriched plasma proteomes between term and preterm neonates over the first days of life: post hoc analysis of a prospective observational study
  8. AI-enabled forecasting of prehospital transfusion needs in patients with trauma: a multinational, registry-based, retrospective, machine learning development and validation study
  9. Nanoparticle Tracking Analysis and Its Application to Study the Role of Small Extracellular Vesicles in Health and Disease
  10. An optimized protocol to isolate quiescent washed platelets from human whole blood and generate platelet releasate under clinical conditions
  11. Toward standardization and a concerted vision for platelet proteomics research: communication from the SSC of the ISTH
  12. Direct Oral Anticoagulants Are Comparable to Low Molecular Weight Heparin at Sustaining the Circulating Extracellular Vesicle and Inflammatory Profiles of Cancer Associated Thrombosis Patients: An Observational Pilot Study
  13. Production of platelets <i>in vitro</i> in functionalised 3-dimensional scaffolds mimicking the bone marrow niche
  14. Unique Patterns of Circulating Extracellular Vesicles in Preterm Infants During Adaptation to Extra‐Uterine Life
  15. Rivaroxaban, in combination with low-dose aspirin, is associated with a reduction in proinflammatory and prothrombotic circulating vesicle signatures in patients with cardiovascular disease
  16. Characterisation of Platelet Releasate Proteome in Relapsing‐Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics
  17. Increasing clinical recruitment rate to a single-site observational study: a quality improvement study
  18. Platelet-derived extracellular vesicles in cardiovascular disease and treatment – from maintaining homeostasis to targeted drug delivery
  19. Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms
  20. Extracellular vesicles in disorders of hemostasis following traumatic brain injury
  21. The effect of UVA light/8-methoxypsoralen exposure used in Extracorporeal Photopheresis treatment on platelets and extracellular vesicles
  22. Proteomic Analysis of Extracellular Vesicle Cargoes Mirror the Cardioprotective Effects of Rivaroxaban in Patients with Venous Thromboembolism
  23. Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism
  24. Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasms
  25. The effect of UVA light/8-methoxypsoralen exposure used in Extracorporeal Photopheresis treatment on platelets and extracellular vesicles
  26. OC 16.5 Rivaroxaban in Combination with Low-Dose Aspirin is Associated with a Reduction in Pro-Inflammatory and Pro-thrombotic Circulating Vesicle Signatures in Patients with Cardiovascular Disease
  27. OC 56.1 Platelets as Versatile Effectors of Thromboinflammation: An MPN Multi-Omics Collaborative
  28. PB1520 Deep Learning Extracts Embedded Signatures Associated with Pregnancy and Preeclampsia from Circulating Vesicle Profiles
  29. Markers of platelet activation foR identification of late onset sEpsis in infaNTs: PARENT study protocol
  30. Translating genomic tools to Raman spectroscopy analysis enables high-dimensional tissue characterization on molecular resolution
  31. Calibrated automated thrombography demonstrates a hypocoagulable profile in subjects with pulmonary arterial hypertension
  32. An optimized protocol to isolate quiescent washed platelets from human whole blood and generate platelet releasate under clinical conditions
  33. AI in Haematology
  34. Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells
  35. Analysis of the Platelet Proteome Reveals Insights into the Pro-Inflammatory and Pro-Thrombotic State Associated with the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
  36. PO-08: Characterisation of plasma extracellular vesicles in myeloproliferative neoplasms
  37. ACKR3 regulates platelet activation and ischemia-reperfusion tissue injury
  38. Non‐severe COVID‐19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis
  39. Case Report: Hypergranular Platelets in Vaccine-Induced Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination
  40. A dry immersion model of microgravity modulates platelet phenotype, miRNA signature, and circulating plasma protein biomarker profile
  41. COVID-19 Is Associated with Endothelial Dysfunction and Enhanced Plasma Thrombin Generation Despite Pharmacological Thromboprophylaxis
  42. Comprehensive Multi-Parameter Characterisation of Circulating Extracellular Vesicles from Rivaroxaban-Treated VTE Patients Reveals Reduced Inflammation and Ameliorated Endothelial Dysfunction
  43. The Effect of Platelets on Thrombin Generation in Cord Blood and Peripheral Neonatal Blood in the Premature Infant; The Event Study
  44. Haematological parameters and coagulation in umbilical cord blood following COVID-19 infection in pregnancy
  45. Platelets in pediatric and neonatal sepsis: novel mediators of the inflammatory cascade
  46. Nonvalvular atrial fibrillation patients anticoagulated with rivaroxaban compared with warfarin exhibit reduced circulating extracellular vesicles with attenuated pro‐inflammatory protein signatures
  47. P-001. AI_PREMie: A novel risk stratification tool for preeclamptic-toxaemia
  48. The role of the calibrated automated thrombogram in neonates: describing mechanisms of neonatal haemostasis and evaluating haemostatic drugs
  49. Routine Hematological Parameters May Be Predictors of COVID-19 Severity
  50. Function, Proteomic and miRomic Study of a Dry Immersion Model of Microgravity implicates the Wnt/Dkk1/AXIN1 axis in Prothrombotic Platelet Phenotype
  51. Platelets, extracellular vesicles and coagulation in pulmonary arterial hypertension
  52. COVID-19 induces a hyperactive phenotype in circulating platelets
  53. The canine activated platelet secretome (CAPS): A translational model of thrombin‐evoked platelet activation response
  54. A review of the role of extracellular vesicles in neonatal physiology and pathology
  55. COVID-19 induces a hyperactive phenotype in circulating platelets
  56. Comparative Platelet Releasate Proteomic Profiling of Acute Coronary Syndrome versus Stable Coronary Artery Disease
  57. Pathophysiology of the Venous Thromboembolism Risk in Preeclampsia
  58. Rivaroxaban Reduces the Levels of Extracellular Vesicles in Patients with Venous Thromboembolism and Non-Valvular Atrial Fibrillation
  59. Alterations in fibrin formation and fibrinolysis in early onset-preeclampsia: Association with disease severity
  60. Examining gender effects in different types of undergraduate science assessment
  61. Computational and experimental analysis of bioactive peptide linear motifs in the integrin adhesome
  62. Liver stiffness and thrombin generation in compensated cirrhosis
  63. Platelet-Derived Microparticles From Obese Individuals: Characterization of Number, Size, Proteomics, and Crosstalk With Cancer and Endothelial Cells
  64. Characterization of Platelet Activation in Patients with Eisenmenger Syndrome
  65. The Hundred-Person Platelet Releasate Project (100PREPs): A Barcode for Human Health and Disease
  66. The Population of Circulating Extracellular Vesicles Dramatically Alters after Very Premature Delivery- a Previously Unrecognised Postnatal Adaptation Process?
  67. The Platelet Releasate is Altered in Human Pregnancy
  68. Front Cover: Platelet Releasate Proteome Profiling Reveals a Core Set of Proteins with Low Variance between Healthy Adults
  69. Platelet Releasate Proteome Profiling Reveals a Core Set of Proteins with Low Variance between Healthy Adults
  70. Dual endothelin-1 receptor antagonism attenuates platelet-mediated derangements of blood coagulation in Eisenmenger syndrome
  71. Proteomic Analysis Reveals a Strong Association of β-Catenin With Cadherin Adherens Junctions in Resting Human Platelets
  72. Early onset preeclampsia is associated with an elevated mean platelet volume (MPV) and a greater rise in MPV from time of booking compared with pregnant controls: results of the CAPE study
  73. Thrombin generation correlates with disease duration in multiple sclerosis (MS): Novel insights into the MS-associated prothrombotic state
  74. A Protocol for Improved Precision and Increased Confidence in Nanoparticle Tracking Analysis Concentration Measurements between 50 and 120 nm in Biological Fluids
  75. Endothelial barrier protective properties of low molecular weight heparin: A novel potential tool in the prevention of cancer metastasis?
  76. Effect of platelet-derived β-thromboglobulins on coagulation
  77. Comparative proteomic analysis of trophoblast cell models reveals their differential phenotypes, potential uses, and limitations
  78. Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype
  79. Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia
  80. Analysis of the proteins associated with platelet detergent resistant membranes
  81. Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activation
  82. 780: Coagulation balance in early onset preeclampsia (EOP)
  83. Human Platelet Exosome Proteomics Leads to the Identification of WNT Positive Exosomes Which Impact Canonical WNT Signalling in Target Cells
  84. Platelet Derived Exosomes Are Enriched for Specific microRNAs Which Regulate WNT Signalling in Endothelial Cells
  85. Canonical Wnt signaling in megakaryocytes regulates proplatelet formation
  86. WNT-3a modulates platelet function by regulating small GTPase activity
  87. The MEIS1 Interactome in Megakaryocytes Reveals a Role in Cell Cycle Regulation,
  88. Novel Platelet Signalling Pathways Identified via Proteomics
  89. Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods
  90. Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function
  91. Canonical Wnt signaling negatively regulates platelet function
  92. Differential stimulation of monocytic cells results in distinct populations of microparticles
  93. Differential Stimulation of Monocytic Cells Results in Distinct Populations of Microparticles
  94. Identification of Apolipoprotein AI as a serum biomarker of chronic kidney disease in liver transplant recipients, using proteomic techniques
  95. A proteomic approach to immune-mediated epithelial-mesenchymal transition
  96. Analysis of membrane microdomain-associated proteins in the insular cortex of post-mortem human brain
  97. Role of Streptococcus gordonii Surface Proteins SspA/SspB and Hsa in Platelet Function
  98. Insights into the Platelet Releasate
  99. Recent Advances in the Characterisation of the Platelet Membrane System by Proteomics
  100. Moderation of the platelet releasate response by aspirin
  101. Correlation of probioticLactobacillus salivariusgrowth phase with its cell wall-associated proteome
  102. Using proteomics to identify potential therapeutic targets in platelets
  103. Characterization of Platelet Lipid Rafts Leads to the Identification of RGS-19, Which Forms a Phosphorylation-Dependent Complex with 14-3-3ζ.
  104. Differential Agonist Stimulated Cytokine Release from Platelets: A Proteomics Approach.
  105. Application of Proteomics to the Study of Platelet Regulatory Mechanisms
  106. Utilising proteomics to elucidate signalling pathways in the formation of platelet thrombin
  107. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions
  108. Integration of Proteomics and Genomics in Platelets
  109. Platelet proteomics
  110. Proteomic analysis of proteins secreted by platelets
  111. Platelet Proteomics: Identification of Potential Therapeutic Targets
  112. Identification of the phosphotyrosine proteome from thrombin activated platelets
  113. Effects of chronic low-frequency stimulation on Ca 2+ -regulatory membrane proteins in rabbit fast muscle
  114. Role of dystrophin isoforms and associated proteins in muscular dystrophy (review).
  115. Oligomerisation of calsequestrin from rabbit skeletal muscle
  116. Excitation-contraction-relaxation cycle: role of Ca2+-regulatory membrane proteins in normal, stimulated and pathological skeletal muscle (review).
  117. Oligomerization Is an Intrinsic Property of Calsequestrin in Normal and Transformed Skeletal Muscle
  118. Oligomerization of sarcoplasmic reticulum Ca2+-ATPase from rabbit skeletal muscle
  119. Enrichment of Phosphotyrosine Proteome of Human Platelets by Immunoprecipitation
  120. Isolation of the Platelet Releasate
  121. Platelet–Endothelial Interactions